Huakang Biomedical (08622) completed placement of 31 million shares to raise approximately HK$2.96 million
Huakang Biomedical (08622) issued an announcement. The conditions for the placement have been met, and on April 2, 2024...
Zhitong FinanceApr 23 07:27 ET
Huakang Biomedical (08622.HK): Chen Jiansheng Resigns as Independent Non-Executive Director
Huakang Biomedical (08622.HK) announced that Chen Jiansheng resigned as an independent non-executive director of the company, a member of the Audit Committee and Nomination Committee in order to invest more time in his personal business and other matters, effective April 2, 2024.
Gelonghui FinanceApr 2 05:01 ET
華康生物醫學:截至二零二三年十二月三十一日止年度的年度業績公告
Futu NewsMar 28 08:53 ET · Announcements
Huakang Biomedical (08622) Fa Ying Guang expects annual shareholders' losses to be no more than 5.8 million yuan
Huakang Biomedical (08622) issued an announcement that it is expected that the company owner's losses during the period will end in December 2023...
Zhitong FinanceMar 25 07:35 ET
HUAKANG BIOMED: PROFIT WARNING
Futu NewsMar 25 07:33 ET · Announcements
Huakang Biomedical (08622) completed the placement of a total of 31 million shares to raise approximately HK$3.18 million
Huakang Biomedical (08622) issued an announcement. The conditions for the placement have been met, and on March 2, 2024...
Zhitong FinanceMar 21 06:32 ET
Huakang Biomedical (08622) has signed a memorandum of understanding with respect to potential sales and distribution cooperation in China
According to Zhitong Finance App News, Huakang Biomedical (08622) announced that Huakang Hong Kong, a direct wholly-owned subsidiary of the company, signed a memorandum of understanding with Fujig after the trading session on February 20, 2024. The details include potential sales and distribution cooperation in China (including) selling and distributing the company's biological agents and immediate biomedical testing products on the platforms and channels of Fujig in China. Other than a few provisions (including due diligence, validity and exclusivity, confidentiality, and applicable law and jurisdiction), the MOU is not legally binding. The directors believe that if cooperation with pig saving is implemented, it will be
Zhitong FinanceFeb 20 05:06 ET
Huakang Biomedical sold 652.24 million issued shares by controlling shareholder Ever Charming
Huakang Biomedical (08622) announced that on January 25, 2024, Ever Charming, the controlling shareholder of the company, sold 652.24 million issued shares of the company (15.59% of the total number of shares issued by the company on the date of this announcement) to a company at a cost of HK$3.2 million. After the sale is completed, the buyer will hold 652.24 million shares (accounting for about 15.59% of the company's total issued share capital at the date of this announcement) and become the company's main shareholder (see listing rules for definition), and Ever Charming and Zhang Xianyang will no longer hold public shares
新浪港股Jan 25 19:55 ET
Huakang Biomedical (08622) sold 65.224 million issued shares by controlling shareholder Ever Charming
Huakang Biomedical (08622) announced that on January 25, 2024, the company's controlling shareholder Ever...
Zhitong FinanceJan 25 09:37 ET
Huakang Biomedical (08622) was reduced by 5.36 million shares of the company by the controlling shareholder Crystal Grant
Huakang Biomedical (08622) announced that the company's board of directors was awarded the company's controlling shareholder Crystal Gr...
Zhitong FinanceJan 10 09:03 ET
Huakang Biomedical Holdings Vice Chairman Yim Yang Chang Sells 31% Of Holding
Anyone interested in Huakang Biomedical Holdings Company Limited (HKG:8622) should probably be aware that the Vice Chairman, Yim Yang Chang, recently divested HK$2.9m worth of shares in the company, a
Simply Wall StDec 30, 2023 19:57 ET
HUAKANG BIOMED: 2023 Third Quarterly Report
Futu NewsNov 14, 2023 04:39 ET · Announcements
HUAKANG BIOMED: THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
Futu NewsNov 14, 2023 04:35 ET · Announcements
HUAKANG BIOMED: 2023 INTERIM REPORT
Futu NewsAug 14, 2023 05:25 ET · Announcements
HUAKANG BIOMED: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Futu NewsAug 9, 2023 09:07 ET · Announcements
HUAKANG BIOMED: NOTIFICATION OF BOARD MEETING
Futu NewsJul 28, 2023 05:31 ET · Announcements
HUAKANG BIOMED: 2023 First Quarterly Report
moomoo NewsMay 15, 2023 05:07 ET · Announcements
HUAKANG BIOMED: FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH 2023
moomoo NewsMay 12, 2023 08:57 ET · Announcements
Huakang Biomedical: 2022 Report
moomoo NewsMar 31, 2023 05:53 ET · Announcements
Huakang Biomedical: Annual Results Announcement for the Year Ended December 31, 2022
moomoo NewsMar 24, 2023 10:08 ET · Announcements
No Data
No Data